Aims. Arthroplasties of the elbow, including total elbow arthroplasty, radial head arthroplasty, distal humeral hemiarthroplasty, and radiocapitellar arthroplasty, are rarely undertaken. This scoping review aims to outline the current research in this area to inform the development of future research. Methods. A scoping review was undertaken adhering to the Joanna Briggs Institute guidelines using Medline, Embase, CENTRAL, and trial registries, limited to studies published between 1 January 1990 and 7 February 2021. Endnote software was used for screening and selection, and included randomized trials, non-randomized controlled trials, prospective and retrospective cohort studies, case-control studies, analytical cross-sectional studies, and case series of ten or more patients reporting the clinical outcomes of elbow arthroplasty. The results are presented as the number of types of studies, sample size, length of follow-up, clinical outcome domains and instruments used, sources of funding, and a narrative review. Results. A total of 362 studies met the inclusion criteria. Most were of total elbow arthroplasty (246; 68%), followed by radial head arthroplasty (100; 28%), distal humeral hemiarthroplasty (11; 3%), and radiocapitellar arthroplasty (5; 1%). Most were retrospective (326; 90%) and observational (315; 87%). The median sample size for all types of implant across all studies was 36 (interquartile range (IQR) 21 to 75). The median length of follow-up for all studies was 56 months (IQR 36 to 81). A total of 583 unique
Aims. Radial head arthroplasty (RHA) may be used in the treatment of
non-reconstructable radial head fractures. The aim of this study
was to evaluate the mid-term clinical and radiographic results of
RHA. Patients and Methods. Between 2002 and 2014, 77 RHAs were implanted in 54 men and 23
women with either acute injuries (54) or with traumatic sequelae
(23) of a fracture of the radial head. Four designs of RHA were
used, including the Guepar (Small Bone Innovations (SBi)/Stryker;
36), Evolutive (Aston Medical; 24), rHead RECON (SBi/Stryker; ten)
or rHead STANDARD (SBi/Stryker; 7) prostheses. The mean follow-up
was 74.0 months (standard deviation (. sd. ) 38.6; 24 to 141).
The indication for further surgery, range of movement, mean Mayo
Elbow Performance (MEP) score, quick Disabilities of the Arm, Shoulder
and Hand (quickDASH) score, osteolysis and positioning of the implant
were also assessed according to the design, and acute or delayed
use. Results. The mean MEP and quickDASH scores were 90.2 (. sd. 14;
45 to 100), and 14.0 points (. sd. 12; 1.2 to 52.5), respectively. There
were no significant differences between RHA performed in acute or
delayed fashion. There were 30 re-operations (19 with, and 11 without
removal of the implant) during the first three post-operative years.
Painful loosening was the primary indication for removal in 14 patients.
Short-stemmed prostheses (16 mm to 22 mm in length) were also associated
with an increased risk of painful loosening (odds ratio 3.54 (1.02
to 12.2), p = 0.045). Radiocapitellar instability was the primary
indication for re-operation with retention of the implant (5). The
overall survival of the RHA, free from re-operation, was 60.8% (. sd. 5.7%)
at ten years. Conclusion. Bipolar and press-fit RHA gives unsatisfactory mid-term outcomes
in the treatment of acute fractures of the radial head or their
sequelae. The
Aims. Favourable short-term
Aims. This study aimed to assess the impact of using the metal-augmented glenoid baseplate (AGB) on improving clinical and radiological
Aims. The aim of this study was to longitudinally compare the clinical and radiological
Aims. There are concerns regarding complications and longevity of total elbow arthroplasty (TEA) in young patients, and the few previous publications are mainly limited to reports on linked elbow devices. We investigated the clinical outcome of unlinked TEA for patients aged less than 50 years with rheumatoid arthritis (RA). Methods. We retrospectively reviewed the records of 26 elbows of 21 patients with RA who were aged less than 50 years who underwent primary TEA with an unlinked elbow prosthesis. The mean patient age was 46 years (35 to 49), and the mean follow-up period was 13.6 years (6 to 27).
Aims. Reverse total shoulder arthroplasty (RTSA) using trabecular metal (TM)-backed glenoid implants has been introduced with the aim to increase implant survival. Only short-term reports on the
Aims. The aim of this study was to compare the characteristics and
Aims. To evaluate the
Aims. Acute distal biceps tendon repair reduces fatigue-related pain and minimizes loss of supination of the forearm and strength of flexion of the elbow. We report the short- and long-term
Aims. To investigate the impact of the Charlson and Elixhauser comorbidity indices on patient-reported
Aims. The aim of this study was to evaluate the
Aims. The impact of tobacco use on readmission and medical and surgical complications has been documented in hip and knee arthroplasty. However, there remains little information about the effect of smoking on the
The purpose of this study was to compare clinical results, long-term survival, and complication rates of stemless shoulder prosthesis with stemmed anatomical shoulder prostheses for treatment of osteoarthritis and to analyze radiological bone changes around the implants during follow-up. A total of 161 patients treated with either a stemmed or a stemless shoulder arthroplasty for primary osteoarthritis of the shoulder were evaluated with a mean follow-up of 118 months (102 to 158). The Constant score (CS), the Disabilities of the Arm, Shoulder and Hand (DASH) score, and active range of motion (ROM) were recorded. Radiological analysis for bone adaptations was performed by plain radiographs. A Kaplan-Meier survivorship analysis was calculated and complications were noted.Aims
Methods
Aims . Few studies have evaluated the relationship between patients’
pre-operative expectations and the
Aims. The number of rotator cuff repairs that are undertaken is increasing. Reverse shoulder arthroplasty (RSA) is the procedure of choice for patients with rotator cuff arthropathy. We sought to determine whether patients who underwent rotator cuff repair and subsequent RSA had different
Aims. The aim of this study was to investigate the effects of preoperative bisphosphonate treatment on the intra- and postoperative
Aims. The aims of this study were to investigate any possible relationship
between a preoperative sensitivity to pain and the degree of pain
at rest and on exertion with postoperative function in patients
who underwent stemless total shoulder arthroplasty (TSA). Patients and Methods. In this prospective study, we included 63 patients who underwent
stemless TSA and were available for evaluation one year postoperatively.
There were 31 women and 32 men; their mean age was 71 years (53
to 89). The pain threshold, which was measured using a Pain Matcher
(PM) unit, the degree of pain (visual analogue scale at rest and
on exertion, and function using the short version of the Disabilities
of the Arm, Shoulder and Hand questionnaire (QuickDASH), were recorded
preoperatively, as well as three and 12 months postoperatively. Results. We found an inverse relationship between both the preoperative
PM threshold and pain (VAS) at rest and the 12-month postoperative
QuickDASH score (Pearson correlation coefficient (r) ≥ 0.4, p < 0.05).
A linear regression analysis showed that the preoperative PM threshold
on the affected side and preoperative pain (VAS) at rest were the
only factors associated with the QuickDASH score at 12 months. Conclusion. These findings indicate the importance of central sensitization
in the restoration of function after TSA. Further studies are required
to investigate whether extra analgesia and rehabilitation could
influence the
Aims. We conducted a study to identify factors that are prognostic
of the
Aims. Improvements in the evaluation of